Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
Int. braz. j. urol ; 44(5): 947-951, Sept.-Oct. 2018. tab
Article in English | LILACS | ID: biblio-975642

ABSTRACT

ABSTRACT Objectives: To investigate the seasonal variations in urinary calcium, serum vitamin D, and urinary volume in patients with a history of nephrolithiasis. Materials and Methods: Patients included were those who completed a 24-hour urine metabolic evaluation on two occasions; one in summer (June-Aug) and one in winter (Nov-Jan), and who had not started any medications or been instructed on dietary modifications in the interval between the two tests that may have impacted the results. Patients were excluded if they were on thiazide diuretics or were taking calcium and / or Vitamin D supplementation. Welch's t-test was used to compare the difference in average summer and winter values. Unpaired Student t-test was used to compare baseline parameters (age, BMI), and Paired Student t-test was used to compare average seasonal measurements in men vs. women. Results: 136 patients were identified who were not taking calcium or vitamin D supplements or thiazide diuretics, and who were not instructed on dietary modifications in the interval between the two measured parameters. No significant differences were observed when comparing male to female baseline parameters of age or BMI (Table-1). Average 24-hour urine calcium was higher (226.60) in the winter than in summer (194.18) and was significant in males (p = 0.014) and females (p < 0.001). No significant seasonal difference was seen in 24-hour urine volume or serum vitamin D levels. Conclusions: Urinary calcium is higher in winter months compared to summer months. As such, tailoring medical preventative strategies to the time of year may be helpful.


Subject(s)
Humans , Female , Vitamin D/urine , Kidney Calculi/urine , Calcium/urine , Seasons , Kidney Calculi/etiology , Retrospective Studies , Urinalysis , Middle Aged
2.
Int. braz. j. urol ; 43(5): 880-886, Sept.-Oct. 2017. tab, graf
Article in English | LILACS | ID: biblio-892890

ABSTRACT

ABSTRACT Background: With a high rate of recurrence, urolithiasis is a chronic disease that impacts quality of life. The Patient Reported Outcomes Measurement Information System is an NIH validated questionnaire to assess patient quality of life. We evaluated the impact of urolithiasis on quality of life using the NIH-sponsored PROMIS-43 questionnaire. Materials and Methods: Patients reporting to the kidney stone clinic were interviewed to collect information on stone history and demographic information and were asked to complete the PROMIS-43 questionnaire. Quality of life scores were analyzed using gender and age matched groups for the general US population. Statistical comparisons were made based on demographic information and patient stone history. Statistical significance was P<0.05. Results: 103 patients completed the survey. 36% of respondents were male, the average age of the group was 52 years old, with 58% primary income earners, and 35% primary caregivers. 7% had never passed a stone or had a procedure while 17% passed 10 or more stones in their lifetime. Overall, pain and physical function were worse in patients with urolithiasis. Primary income earners had better quality of life while primary caregivers and those with other chronic medical conditions were worse. Patients on dietary and medical therapy had better quality of life scores. Conclusions: Urolithiasis patients subjectively have worse pain and physical function than the general population. The impact of pain on quality of life was greatest in those patients who had more stone episodes, underscoring the importance of preventive measures. Stone prevention measures improve quality of life.


Subject(s)
Humans , Male , Female , Adult , Aged , Quality of Life/psychology , Urolithiasis/psychology , Patient Reported Outcome Measures , Pain/etiology , Pain/psychology , Sleep Wake Disorders/etiology , Sleep Wake Disorders/psychology , Information Systems , Case-Control Studies , Chronic Disease , Surveys and Questionnaires , Depression/etiology , Depression/psychology , Urolithiasis/complications , Fatigue/etiology , Fatigue/psychology , Middle Aged
3.
Int. braz. j. urol ; 43(2): 239-244, Mar.-Apr. 2017. tab
Article in English | LILACS | ID: biblio-840836

ABSTRACT

ABSTRACT Introduction Urinalysis (UA) in the emergency setting for patients with nephrolithiasis produces potentially confusing results leading to treatment of presumed urinary tract infections (UTIs). Our objective was to evaluate the use of antibiotics in patients with nephrolithiasis in a large network of emergency departments (EDs). Methods A retrospective analysis of all ED visits associated with an ICD-9 diagnosis of nephrolithiasis and a CT scan between 2010 and 2013 was performed. Urinalysis data, the use of IV and PO antibiotics during the ED visit and at discharge were assessed. The presence of fever, elevated serum WBCs, >5 WBCs per hpf, and/or dip positive nitrites were used as appropriate criteria for antibiotic use. Results Urinalysis data were available for 3,518 (70%) of 5,035 patients with an ED diagnosis of nephrolithiasis and CT imaging. Of these visits, 237 patients had positive nitrites (6.7%) and 864 had >5 WBCs per hpf (24.6%) with 158 (4.5%) having both findings for a total of 943 patients. Intravenous antibiotics were given to 244 patients (25.9%) and oral antibiotics were given to 629 patients (66.7 %) with positive UA findings. Of the 2,440 patients with a negative UA and no leukocytosis or fever, 86 patients (3.5%) received IV antibiotics and 533 patients (21.8%) received PO antibiotics upon discharge. Conclusions Proper treatment of nephrolithiasis in the ED includes the screening and diagnosis of concomitant UTIs. However, correct interpretation of UA studies is vital to the correct implementation of antibiotic therapy. This study suggests that 1/3 of patients were undertreated and 21.8% were over-treated.


Subject(s)
Humans , Male , Female , Adult , Nephrolithiasis/drug therapy , Renal Colic/drug therapy , Anti-Bacterial Agents/therapeutic use , Urinary Tract Infections/drug therapy , Pain Measurement , Multivariate Analysis , Retrospective Studies , Treatment Outcome , Emergency Service, Hospital/statistics & numerical data , Leukocyte Count , Middle Aged
4.
Int. braz. j. urol ; 41(1): 134-138, jan-feb/2015. graf
Article in English | LILACS | ID: lil-742866

ABSTRACT

Objective To identify whether stabilization of larger bladder stones would improve the efficacy of combination (ultrasonic/pneumatic) lithotripsy in a phantom bladder stone model for percutaneous cystolithopaxy. Materials and Methods Using 1cm phantom Bego stones, a spherical model bladder was used to simulate percutaneous bladder access. A UroNet (US Endoscopy, USA) was placed alongside a Swiss Lithoclast probe through the working channel of a Storz 26Fr rigid nephroscope. Using a 30Fr working sheath, the stone was captured, and fragmented for 60seconds. Resulting fragments and irrigation were filtered through a 1mm strainer, and recorded. Five trials were performed with and without the UN. Durability was then assessed by measuring net defects, and residual grasp strength of each instrument. Descriptive statistics (mean, standard deviations) were used to summarize the data, and Student’s t-tests (alpha<0.05) were used to compare trials. Results The mean time to stone capture was 12s (8-45s). After fragmentation with UN stabilization, there were significant improvements in the amount of residual stone (22% dry weight reduction vs 8.1% without UN, p<0.001), number of fragments (17.5 vs 5.0 frag/stone, p=0.0029), and fragment size (3.6mm vs. 7.05 mm, p=0.035). Mesh defects were noted in all nets, ranging from 2-14 mm, though all but one net retained their original grip strength (36.8N). Conclusions Bladder stone stabilization improved fragmentation when used in conjunction with ultrasonic/pneumatic lithotripsy. However, due to limitations in maneuverability and durability of the UN, other tools need to identified for this indication. .


Subject(s)
Lithotripsy/instrumentation , Lithotripsy/methods , Urinary Bladder Calculi/therapy , Equipment Design , Medical Illustration , Reproducibility of Results , Time Factors
5.
Int. braz. j. urol ; 39(4): 579-586, Jul-Aug/2013. tab, graf
Article in English | LILACS | ID: lil-687307

ABSTRACT

Purpose to test the effect of stone entrapment on laser lithotripsy efficiency. Materials and Methods Spherical stone phantoms were created using the BegoStone® plaster. Lithotripsy of one stone (1.0g) per test jar was performed with Ho:YAG laser (365µm fiber; 1 minute/trial). Four laser settings were tested: I-0.8J,8Hz; II-0.2J,50Hz; III-0.5J,50Hz; IV-1.5J,40Hz. Uro-Net (US Endoscopy) deployment was used in 3/9 trials. Post-treatment, stone fragments were strained though a 1mm sieve; after a 7-day drying period fragments and unfragmented stone were weighed. Uro-Net nylon mesh and wire frame resistance were tested (laser fired for 30s). All nets used were evaluated for functionality and strength (compared to 10 new nets). Student's T test was used to compare the studied parameters; significance was set at p < 0.05. Results Laser settings I and II caused less damage to the net overall; the mesh and wire frame had worst injuries with setting IV; setting III had an intermediate outcome; 42% of nets were rendered unusable and excluded from strength analysis. There was no difference in mean strength between used functional nets and non-used devices (8.05 vs. 7.45 lbs, respectively; p = 0.14). Setting IV was the most efficient for lithotripsy (1.9 ± 0.6 mg/s; p < 0.001) with or without net stabilization; setting III was superior to I and II only if a net was not used. conclusions Laser lithotripsy is not optimized by stone entrapment with a net retrieval device which may be damaged by high energy laser settings. .


Subject(s)
Lasers, Solid-State/therapeutic use , Lithotripsy, Laser/instrumentation , Lithotripsy, Laser/methods , Nephrostomy, Percutaneous/methods , Urinary Calculi/therapy , Equipment Design , Materials Testing , Medical Illustration , Reproducibility of Results , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL